Abstract
Anthracyclines and taxanes are to date the most active cytotoxic agents in the treatment of breast cancer, and a combination of these is therefore considered to result in the highest response rates in the neoadjuvant, as well as in palliative treatment. These two phase II studies aimed to evaluate the feasibility, toxicity and activity of a cytostatic regimen combining epidoxorubicin and docetaxel in outpatient patients suffering from breast cancer. In total, 104 consecutive patients were enrolled in these prospective clinical trials. The chemotherapeutic regimen consisted of epidoxorubicin [75 mg/m2 body surface area (BSA)] and docetaxel (75 mg/m2 BSA) on day 1 accompanied by the administration of granulocyte colony stimulating factor on days 3-10, repeated every 3 weeks (ED+G). Sixty-six patients received ED+G as neoadjuvant and 38 patients as palliative treatment, respectively. Patients received a total of 566 cycles (median: 6 cycles, range: 2-11 cycles) of this therapeutic regimen. Outpatient ED+G was well tolerated. A major response to preoperative ED+G could be demonstrated in 54 of 66 patients (82%) and in 22 of 38 palliative treated patients (58%). We conclude that outpatient ED+G is safe in the neoadjuvant and palliat...Continue Reading
References
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jun 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Italian Multicentre Breast Study with EpirubicinC Intini
Jan 1, 1981·Cancer·A B MillerA Winkler
Nov 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L GianniC Martini
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B S ReichmanC A Hudis
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M SchollP Beuzeboc
Dec 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V ValeroG N Hortobagyi
Feb 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G Bonadonna
Aug 1, 1996·British Journal of Cancer·V DierasP Fumoleau
Sep 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J GehlP Dombernowsky
Jul 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherN V Dimitrov
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M N LevineD Tu
Mar 13, 1999·Seminars in Oncology Nursing·K G O'Connor
Sep 3, 1999·Breast Cancer Research and Treatment·C PazosA Suárez
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GennariP F Conte
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SparanoW C Wood
Jun 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SparanoW C Wood
Oct 19, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O PaganiA Goldhirsch
Dec 6, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D MavroudisV Georgoulias
Feb 28, 2001·Cancer Chemotherapy and Pharmacology·M SchmidingerG G Steger
Citations
Sep 27, 2005·Breast Cancer Research and Treatment·Bhuvaneswari RamaswamyCharles L Shapiro
Oct 25, 2006·Breast Cancer Research and Treatment·Catharina WenzelGuenther G Steger
Jun 11, 2009·Medical Oncology·Zeina Nahleh
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Steven D HeysAndrew W Hutcheon
Aug 25, 2015·International Journal of Pharmaceutics·Zhen LiangPingping Zuo
Aug 22, 2006·Cancer Letters·Valentina GuarneriPierFranco Conte
Oct 15, 2003·Cancer Chemotherapy and Pharmacology·Serafín MoralesCristina Llorca
Oct 15, 2008·Biomaterials·Zhenghong XuYaping Li
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M SandströmM O Karlsson
Oct 23, 2009·Biomaterials·Zhenghong XuYaping Li
Mar 5, 2005·Anti-cancer Drugs·Catharina WenzelGuenther G Steger
Apr 2, 2005·Breast Cancer Research and Treatment·Steven D HeysAndrew W Hutcheon
Apr 8, 2014·The Oncologist·Andrew D SeidmanBinghe Xu
Jun 18, 2020·AAPS PharmSciTech·Pawan TekchandaniShivani Rai Paliwal
Apr 8, 2003·World Journal of Gastroenterology : WJG·Chang-Xin GengJi-Yao Wang
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura G Estévez, William J Gradishar